Overexpression of c-myc is associated with adverse clinical features and worse overall survival in multiple myeloma

Clinicopathological features of plasmablastic multiple myeloma: a population-based cohort

(2015) Hanne E. H. Møller et al.   APMIS

MYC Protein Expression Is Detected in Plasma Cell Myeloma but Not in Monoclonal Gammopathy of Undetermined Significance (MGUS)

(2014) Ruobing Xiao et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma

(2014) M Affer et al.   LEUKEMIA

Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients

(2014) B A Walker et al.   Blood Cancer Journal

MYC translocation partner gene determines survival of patients with large B-cell lymphoma with MYC- or double-hit MYC/BCL2 translocations

(2013) Mette Ø. Pedersen et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

High Levels of Nuclear MYC Protein Predict the Presence of MYC Rearrangement in Diffuse Large B-cell Lymphoma

(2012) Tina Marie Green et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

MYC addiction: a potential therapeutic target in MM

(2012) W. M. Kuehl et al.   BLOOD

Double-hit BCL2/MYC translocations in a consecutive cohort of patients with large B-cell lymphoma - a single centre's experience

(2012) Mette Ø. Pedersen et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents

(2012) S. Z. Usmani et al.   HAEMATOLOGICA

Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma

(2011) W-J Chng et al.   LEUKEMIA

Treatment of multiple myeloma

(2011) S. Vincent Rajkumar   Nature Reviews Clinical Oncology

Multiple Myeloma

(2011) Antonio Palumbo et al.   NEW ENGLAND JOURNAL OF MEDICINE